Monsenso A/S (CPH:MONSO)
Denmark · Delayed Price · Currency is DKK 0.2520
-0.0180 (-6.67%)
Sep 11, 2026, 1:00 PM CET
Monsenso Market Cap
Monsenso has a market cap or net worth of 25.89 million as of September 11, 2026. Its market cap has increased by 58.93% in one year.
Market Cap
25.89M
Enterprise Value
26.70M
Revenue
7.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.25
ChartMarket Cap Chart
Since June 10, 2020, Monsenso's market cap has decreased from 96.87M to 25.89M, a decrease of -73.27%. That is a compound annual growth rate of -19.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 25.89M | 158.53% |
| Dec 30, 2025 | 10.02M | -59.16% |
| Dec 30, 2024 | 24.52M | 177.63% |
| Dec 29, 2023 | 8.83M | -21.75% |
| Dec 30, 2022 | 11.29M | -59.30% |
| Dec 30, 2021 | 27.73M | -82.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.27T |
| Genmab | 124.47B |
| Coloplast | 97.45B |
| Demant | 61.88B |
| Gubra | 5.25B |
| BioPorto | 589.18M |
| ViroGates | 101.17M |
| Pharma Equity Group | 99.43M |